Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Finazzi

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Blood Cancer Journal|June 28, 2018
Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasmsValerio De Stefano, Guido Finazzi, Tiziano Barbui
Blood Cancer Journal|November 9, 2018
Prefibrotic myelofibrosis: treatment algorithm 2018Guido Finazzi, Alessandro M Vannucchi, Tiziano Barbui
Blood Cancer Journal|June 28, 2018
Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018Guido Finazzi, Valerio De Stefano, Tiziano Barbui
Italian Journal of Food Safety|November 18, 2016
FLOQSwab™: Optimisation of Procedures for the Recovery of Microbiological Samples from SurfacesGuido Finazzi, Marina Nadia Losio, Giorgio Varisco
Current Hematologic Malignancy Reports|September 17, 2013
Are MPNs vascular diseases?Guido Finazzi, Valerio De Stefano, Tiziano Barbui
Blood Reviews|July 13, 2012
Front-line therapy in polycythemia vera and essential thrombocythemiaTiziano Barbui, Maria Chiara Finazzi, Guido Finazzi
Blood|April 18, 2009
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?Tiziano Barbui, Alessandra Carobbio, Alessandro Rambaldi, et al.
Blood|April 23, 2003
Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosisGuido Finazzi, Marco Ruggeri, Francesco Rodeghiero, et al.
Haematologica|January 19, 2007
Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation statusGuido Finazzi, Alessandro Rambaldi, Vittoria Guerini, et al.
Blood Cancer Journal|November 9, 2018
Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasmsTiziano Barbui, Guido Finazzi, Alessandro M Vannucchi, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Blood Cancer Journal|June 28, 2018
Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasmsValerio De Stefano, Guido Finazzi, Tiziano Barbui
Blood Cancer Journal|November 9, 2018
Prefibrotic myelofibrosis: treatment algorithm 2018Guido Finazzi, Alessandro M Vannucchi, Tiziano Barbui
Blood Cancer Journal|June 28, 2018
Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018Guido Finazzi, Valerio De Stefano, Tiziano Barbui
Italian Journal of Food Safety|November 18, 2016
FLOQSwab™: Optimisation of Procedures for the Recovery of Microbiological Samples from SurfacesGuido Finazzi, Marina Nadia Losio, Giorgio Varisco
Current Hematologic Malignancy Reports|September 17, 2013
Are MPNs vascular diseases?Guido Finazzi, Valerio De Stefano, Tiziano Barbui
Blood Reviews|July 13, 2012
Front-line therapy in polycythemia vera and essential thrombocythemiaTiziano Barbui, Maria Chiara Finazzi, Guido Finazzi
Blood|April 18, 2009
Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?Tiziano Barbui, Alessandra Carobbio, Alessandro Rambaldi, et al.
Blood|April 23, 2003
Efficacy and safety of long-term use of hydroxyurea in young patients with essential thrombocythemia and a high risk of thrombosisGuido Finazzi, Marco Ruggeri, Francesco Rodeghiero, et al.
Haematologica|January 19, 2007
Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation statusGuido Finazzi, Alessandro Rambaldi, Vittoria Guerini, et al.
Blood Cancer Journal|November 9, 2018
Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasmsTiziano Barbui, Guido Finazzi, Alessandro M Vannucchi, et al.
Pageof 13